EEE

EMYRIA LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪13.29 M‬AUD
−0.034AUD
‪−11.46 M‬AUD
‪2.20 M‬AUD
‪394.75 M‬
Beta (1Y)
−0.52

About EMYRIA LIMITED


CEO
Michael Winlo
Website
Headquarters
Leederville
Founded
2018
ISIN
AU0000073645
FIGI
BBG00R41CR46
Emyria Ltd. is a healthcare technology and services company. It operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from informed and consenting patients. The company was founded on March 19, 2018 and is headquartered in Leederville, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EMD is 0.033 AUD — it hasn't changed in the past 24 hours. Watch EMYRIA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange EMYRIA LIMITED stocks are traded under the ticker EMD.
EMD stock has fallen by −2.94% compared to the previous week, the last month showed zero change in price, over the last year EMYRIA LIMITED has showed a −58.75% decrease.
EMD reached its all-time high on Nov 26, 2021 with the price of 0.488 AUD, and its all-time low was 0.026 AUD and was reached on Oct 4, 2024. View more price dynamics on EMD chart.
See other stocks reaching their highest and lowest prices.
EMD stock is 0.00% volatile and has beta coefficient of −0.52. Track EMYRIA LIMITED stock price on the chart and check out the list of the most volatile stocks — is EMYRIA LIMITED there?
Yes, you can track EMYRIA LIMITED financials in yearly and quarterly reports right on TradingView.
EMYRIA LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
EMD net income for the last half-year is ‪−661.98 K‬ AUD, while the previous report showed ‪−10.79 M‬ AUD of net income which accounts for 93.87% change. Track more EMYRIA LIMITED financial stats to get the full picture.
No, EMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EMYRIA LIMITED EBITDA is ‪−3.68 M‬ AUD, and current EBITDA margin is −281.82%. See more stats in EMYRIA LIMITED financial statements.
Like other stocks, EMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EMYRIA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EMYRIA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EMYRIA LIMITED stock shows the sell signal. See more of EMYRIA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.